FDA: More data needed before Gardasil is approved for older women
(www.feministing.com)
Six months after the FDA rejected Merck and Co.'s request to approve the distribution of Gardasil - the HPV vaccine - to women aged 27 to 45, they've sent a response letter to Merck requesting that they resubmit their request after a full 48-month study.
Submitted about 1 year ago by cdoherty | 0 Comments |

RSS
